Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

This study is testing whether a new injectable medication called HDM1005 can help control blood sugar in people with type 2 diabetes who haven't yet started other diabetes drugs. About 240 participants will receive either the real medication or a placebo injection for 36 weeks, w…

This study is testing a new weekly injection called HDM1005 to see if it helps people lose weight and improve related health issues like high blood pressure. About 825 Chinese adults who are overweight or have obesity, but do not have diabetes, will receive the injection or a pla…

This study is testing whether an investigational injection called HDM1005 can help adults with obesity lose weight. About 240 participants without diabetes will receive either the injection or a placebo for 22 weeks to see how much weight they lose and to check for side effects. …

This study is testing a new topical cream called MC2-01 for adults with plaque psoriasis. It compares the new cream against a standard gel treatment and a placebo cream to see which is better at clearing skin plaques and which is more convenient for patients to use. The main goal…

This study aims to see if a specific combination of three diabetes medications works better and is safer than other oral drug combinations for adults whose type 2 diabetes is not well controlled. It will enroll 430 participants aged 18-75 who are already taking metformin but stil…

This study is testing whether a new pill called HDM1002 can help control blood sugar in adults with type 2 diabetes who haven't yet started medication. It will involve 360 participants who will take either the new pill or a placebo (inactive pill) for one year. The main goal is t…

This is the first human study of an experimental drug called HDM2017 for people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose, see how the drug moves through the body, and check for any early signs that it m…

This is the first study in humans to test a new experimental drug called HDM2006. It aims to find a safe dose and see early signs of whether it can help control advanced solid tumors in patients who have already tried standard treatments without success. The study will enroll abo…

This early-stage study aims to understand how a new investigational drug for weight management, called HDM1002, interacts with five common medications (including metformin for diabetes and warfarin for blood thinning) when taken together. It will enroll 111 overweight or obese bu…